Friday, Jul 24, 2026 The claims desk. Receipts included. POWERED BY LENZ
IsThis

HEALTH

The Claim

Chemotherapy-induced peripheral neuropathy (CIPN) can cause persistent dysfunction of the hands and feet that interferes with daily activities and reduces quality of life.

The Short Version

The evidence strongly supports this statement. Chemotherapy-induced peripheral neuropathy is well documented as sometimes persisting after treatment, especially in the hands and feet, and studies link it to difficulty with daily tasks, falls, disability, and reduced quality of life. The wording is appropriately cautious because it says this can happen, not that it happens to every patient.

Caveats

  • CIPN does not affect every patient, and symptoms are not always permanent; risk, severity, and duration vary by chemotherapy drug, dose, and individual factors.
  • Functional and quality-of-life impacts are most pronounced in patients with persistent or more severe neuropathy, so the claim should not be read as universal.
  • Some cited patient-information or clinic websites are weaker sources, but the core conclusion is supported by peer-reviewed reviews and oncology studies.

The Receipts

  1. Chronic chemotherapy-induced peripheral neuropathy: living with neuropathy during and after cancer treatments - Annals of Palliative Medicine

    Annals of Palliative Medicine

  2. Chemotherapy-Induced Peripheral Neuropathy: Current Status and Progress - PMC - NIH

    PMC - NIH

  3. Long-Term Effects, Pathophysiological Mechanisms, and Risk Factors of Chemotherapy-Induced Peripheral Neuropathies: A Comprehensive Literature Review - PMC

    PMC

  4. [Chemotherapy-induced peripheral neuropathy; impact on quality of life] - PubMed

    PubMed

  5. The global prevalence of peripheral neuropathy following chemotherapy in cancer patients: a systematic review and meta-analysis - PMC

    PMC

  6. Non-pharmacological interventions on pain and quality of life in chemotherapy induced polyneuropathy: systematic review and meta-analysis.

    in vivo

  7. Non-Pharmacological Self-Management Strategies for Chemotherapy-Induced Peripheral Neuropathy in People with Advanced Cancer: A Systematic Review and Meta-Analysis - MDPI

    MDPI

  8. Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study - PMC

    PMC

  9. Impact of Chemotherapy-Induced Peripheral Neuropathy on Quality of Life in Patients with Advanced Lung Cancer Receiving Platinum-Based Chemotherapy - PMC

    PMC

  10. Prevalence and predictors of chemotherapy-induced peripheral neuropathy among female breast cancer patients undergoing chemotherapy in Lagos - PMC

    PMC

+ 12 more sources — see the full list on Lenz

Filed Under

Chemotherapy-Induced Peripheral Neuropathy